journal article·2016-07-23Open access

Copper nanoparticles catalysed an efficient one-pot multicomponents synthesis of chromenes derivatives and its antibacterial activity

Jay A. Tanna, Ratiram Gomaji Chaudhary, Nilesh V. Gandhare, Alok R. Rai, Sachin Yerpude, Harjeet D. Juneja

Abstract

In this study, copper nanoparticles (Cu NPs) were synthesised by using diethylenetriamine as a protective agent in chemical reduction method. The obtained nanoparticles were characterised by various spectroscopic techniques like powder X-ray diffraction (PXRD), Fourier transform infrared (FTIR), UV–visible spectroscopy, energy dispersive spectroscopy (EDS), scanning electron microscopy (SEM), transmission electron microscopy (TEM) and thermal analysis (TG/DTA). The structure and composition were estimated by PXRD, FTIR, EDS, UV–visible and TG/DTA techniques, while particles size and morphology behaviours were investigated by SEM and TEM instrumentation. A noteworthy, average particle size of nanoparticles was found around 40 nm with spherical shapes. Furthermore, the applications part of NPs were studied as a catalyst for one-pot solvent-free green synthesis of 3,4-dihydropyrano[c]chromenes from different aromatic aldehydes, malonitrile and 4-hydroxycoumarin by stirring at 80 °C. Moreover, the antibacterial properties of NPs were assessed in vitro against human bacterial pathogen such as Staphylococcus aureus, Escherichia coli, Klebsiella sp. and Pseudomonas aruginosa using agar well diffusion method. Gram positive bacteria S. aureus (18 mm) exhibited a maximum zone of inhibition at 60 µg/ml of Cu NPs. Nonetheless, antibacterial activities of Cu NPs (10–100 µg) were compared with four well-known antibiotics likes amikacin (30 mcg), ciprofloxacin (5 mcg), gentamicin (5 mcg) and norfloxacin (10 mcg). This study indicates that Cu NPs exhibited a strong antibacterial activity against all the test pathogens even at lower concentration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Multicomponent Synthesis of Heterocycles · Synthesis and Characterization of Heterocyclic Compounds · Synthesis and biological activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

P.G. Department of Chemistry, S.K. Porwal College, R.T.M. Nagpur University, Kamptee, India

P.G. Teaching Department of Chemistry, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India

Department of Chemistry, Nabira Mahavidyalaya, R.T.M. Nagpur University, Katol, India

P.G. Department of Microbiology, S.K. Porwal College, R.T.M. Nagpur University, Kamptee, India

Funding

Science and Engineering Research Board

References (37)

Show source-provided references
1. 10.1021/nn302915s10.1021/nn302915s ↗
2. 10.1080/17458080.2013.84829810.1080/17458080.2013.848298 ↗
3. 10.1080/17458080.2013.81281010.1080/17458080.2013.812810 ↗
4. 10.1016/j.actbio.2007.11.00610.1016/j.actbio.2007.11.006 ↗
5. 10.1016/j.ijantimicag.2008.12.00410.1016/j.ijantimicag.2008.12.004 ↗
6. 10.1016/j.scitotenv.2006.11.00710.1016/j.scitotenv.2006.11.007 ↗
7. 10.1016/j.cclet.2013.10.01610.1016/j.cclet.2013.10.016 ↗
8. 10.3390/app404049310.3390/app4040493 ↗
9. 10.1002/chem.20030504810.1002/chem.200305048 ↗
10. 10.1007/s00706-010-0383-410.1007/s00706-010-0383-4 ↗
11. 10.1016/j.tetlet.2011.08.01910.1016/j.tetlet.2011.08.019 ↗
12. 10.1007/BF0324608410.1007/BF03246084 ↗
13. 10.1021/sc400312n10.1021/sc400312n ↗
14. 10.1007/s00706-013-1066-810.1007/s00706-013-1066-8 ↗
15. 10.1007/s12039-013-0408-810.1007/s12039-013-0408-8 ↗
16. Shaker RMR · Pharmazie. · 1996 · 51 · 148
17. 10.1002/jhet.19310.1002/jhet.193 ↗
18. 10.1002/cjoc.20119021710.1002/cjoc.201190217 ↗
19. 10.1016/j.jtusci.2014.09.00810.1016/j.jtusci.2014.09.008 ↗
20. 10.1016/j.tetlet.2011.06.10110.1016/j.tetlet.2011.06.101 ↗
21. 10.1007/s10562-008-9603-510.1007/s10562-008-9603-5 ↗
22. 10.1016/j.cclet.2010.09.02010.1016/j.cclet.2010.09.020 ↗
23. 10.1016/j.cclet.2011.06.00310.1016/j.cclet.2011.06.003 ↗
24. 10.13005/ojc/30035510.13005/ojc/300355 ↗
25. Chaudhary RG · Adv Mater Lett. · 2015 · 6 · 99010.5185/amlett.2015.5901 ↗
26. 10.1007/s12668-015-0170-010.1007/s12668-015-0170-0 ↗
27. 10.1080/22243682.2015.106813410.1080/22243682.2015.1068134 ↗
28. Hammond SM, Lambert PA. Antimicrobial actions. London: Edward Arnld Ltd; 1978, p. 8–9.
29. CLSI · M2-A9—Document performance standards for antimicrobial disk susceptibility tests · 2006
30. 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
31. 10.1016/j.nano.2011.05.00710.1016/j.nano.2011.05.007 ↗
32. 10.2147/IJN.S3534710.2147/IJN.S35347 ↗
33. 10.1007/s12034-011-0329-410.1007/s12034-011-0329-4 ↗
34. 10.1007/s10973-012-2616-810.1007/s10973-012-2616-8 ↗
35. 10.1080/22243682.2013.81039610.1080/22243682.2013.810396 ↗
36. 10.1016/j.jscs.2014.06.00210.1016/j.jscs.2014.06.002 ↗
37. 10.1007/s10973-011-1671-x10.1007/s10973-011-1671-x ↗